Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial

Domestic measles, mumps, and rubella combined (MMR) vaccines were discontinued in 1993 in Japan because of the unexpected high incidence of aseptic meningitis. The introduction of an effective MMR vaccine with lower reactogenicity has been expected. A new MMR vaccine (JVC-001) was developed, using m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Tetsuo, Eda, Masahiro, Hirano, Motonori, Goto, Wakako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605871/
https://www.ncbi.nlm.nih.gov/pubmed/30724658
http://dx.doi.org/10.1080/21645515.2019.1578591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605871/
https://www.ncbi.nlm.nih.gov/pubmed/30724658
http://dx.doi.org/10.1080/21645515.2019.1578591

Ejemplares similares